Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1962-1978
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1962
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1962
Figure 7 Macrophage clearance enhances intestinal function and improves the epithelium in diabetes mice.
A-J: After 24 hours of treatment with clodronate liposomes, immunofluorescence analysis revealed a substantial decrease in ZO-1 and occludin levels; K and L: The immunofluorescence analysis demonstrated a notable elevation in the protein expression of occludin and ZO-1 following DB. Scale bar = 50 μm. aP < 0.05, cP < 0.001, dP < 0.0001. DB: Diabetes group; Cls: Clodronate liposomes.
- Citation: Lu M, Guo XW, Zhang FF, Wu DH, Xie D, Luo FQ. Dexmedetomidine ameliorates diabetic intestinal injury by promoting the polarization of M2 macrophages through the MMP23B pathway. World J Diabetes 2024; 15(9): 1962-1978
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1962.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1962